Literature DB >> 22760590

Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Ali Azarm1, Ismet Lukolic, Meenal Shukla, Ronald Concha-Parra, Frank Gress.   

Abstract

Barrett's esophagus (BE) is a well-known premalignant condition that can be associated with the development of dysplasia and adenocarcinoma. In the past, esophagectomy was the standard treatment for patients with BE with high grade dysplasia (HGD) and early cancer (EC). However, esophagectomy is not necessarily the only treatment response to HGD and EC anymore. Over the past decade, a number of endoscopic therapies have been developed for management of BE. These include endoscopic mucosal resection, thermal ablation techniques that use laser irradiation, multipolar electrocoagulation, argon plasma coagulation, photodynamic therapy, and the recently developed cryotherapy and radiofrequency ablation.

Entities:  

Mesh:

Year:  2012        PMID: 22760590     DOI: 10.1007/s10620-012-2279-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  100 in total

1.  Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma.

Authors:  J L Van Laethem; R Jagodzinski; M O Peny; M Cremer; J Devière
Journal:  Endoscopy       Date:  2001-03       Impact factor: 10.093

2.  Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.

Authors:  Krish Ragunath; Neville Krasner; V Sankara Raman; Mustafa T Haqqani; Ceri J Phillips; Ivy Cheung
Journal:  Scand J Gastroenterol       Date:  2005-07       Impact factor: 2.423

3.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

4.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

5.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid.

Authors:  W E Grant; C Hopper; A J MacRobert; P M Speight; S G Bown
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

Review 6.  A cost-utility analysis of ablative therapy for Barrett's esophagus.

Authors:  John M Inadomi; Ma Somsouk; Ryan D Madanick; Jennifer P Thomas; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2009-03-06       Impact factor: 22.682

7.  Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.

Authors:  Roger Ackroyd; William Tam; Mark Schoeman; Peter G Devitt; David I Watson
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

8.  Radiofrequency ablation of Barrett's esophagus.

Authors:  Thomas J Watson
Journal:  J Gastrointest Surg       Date:  2009-10-09       Impact factor: 3.452

Review 9.  Total endoscopic resection of Barrett esophagus.

Authors:  S Seewald; T L Ang; T Gotoda; N Soehendra
Journal:  Endoscopy       Date:  2008-12-08       Impact factor: 10.093

10.  Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma.

Authors:  C V Lopes; M Hela; C Pesenti; E Bories; F Caillol; G Monges; M Giovannini
Journal:  Surg Endosc       Date:  2007-02-09       Impact factor: 3.453

View more
  1 in total

1.  Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett's esophagus.

Authors:  Kristen Suchniak-Mussari; Charles E Dye; Matthew T Moyer; Abraham Mathew; Thomas J McGarrity; Eileen M Gagliardi; Jennifer L Maranki; John M Levenick
Journal:  World J Gastrointest Endosc       Date:  2017-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.